One in six patients with lung cancer were still alive five-years after being treated with immunotherapy, tests show. Of 129 sufferers with previously-treated advanced non-small cell lung cancer 16 per cent survived. Typically, five-year survival in advanced lung cancer is just one per cent. The findings for nivolumab were due to be presented at The […]
